Financial Performance - For the six months ended June 30, 2024, the Group reported revenue of HK34,270,000 in the same period of 2023[7]. - The Group incurred a loss before tax of HK46,664,000 in the corresponding period of 2023[7]. - The loss for the period was HK46,664,000 in the same period last year[7]. - For the six months ended June 30, 2024, the company reported a total comprehensive loss of HK75,260 for the same period in 2023, representing a significant decline[8]. - The loss attributable to shareholders for the period was HK46,743 in the prior year, indicating a year-over-year decline of approximately 150%[8]. - Basic and diluted loss per share was HK0.87 per share in the previous year, reflecting a substantial decrease in profitability[8]. Expenses and Costs - Administrative expenses decreased to HK45,905,000, reflecting a reduction of approximately 10%[7]. - The Group's finance costs decreased to HK3,933,000, indicating a reduction of about 19.7%[7]. - Other income and gains amounted to HK2,946,000 in the previous year[7]. - The profit before tax for the period was impacted by an impairment loss on contract assets and accounts receivable amounting to HK5,796,000 in 2023[27]. Assets and Liabilities - Total current assets decreased to HK144,750 as of December 31, 2023, marking a decline of approximately 5.7%[9]. - Non-current assets totaled HK296,752 at the end of 2023, representing a decline of approximately 1.6%[9]. - Total liabilities increased, with current liabilities rising to HK95,958, a decrease of about 9.6%[10]. - The company reported a decrease in cash and cash equivalents to HK32,507, reflecting a decline of approximately 18.5%[9]. - The accumulated losses as of June 30, 2024, were HK848,739,000 as of June 30, 2023[11]. Cash Flow - For the six months ended June 30, 2024, the net cash flow from operating activities was HK23,962,000 in the same period of 2023[13]. - The net cash flow used in investing activities was HK34,669,000 in 2023[13]. - The net cash flow from financing activities was HK19,313,000 in 2023[13]. Segment Performance - For the six months ended June 30, 2024, total segment revenue was HK32,958,000, money lending HK1,000[22]. - The segment profit for hospitality services was a loss of HK194,000, and network media services incurred a loss of HK13,918,000[22]. - Revenue from contracts with customers in hospitality and related services was HK13,308,000, reflecting a growth of 1.6%[25]. - Loan interest income significantly increased to HK2,665,000 in the previous year, marking a growth of 92.5%[25]. Investments - The Group's financial assets at fair value through profit or loss (FVTPL) totaled HK61,697,000 as of December 31, 2023, indicating a decline of about 9.8%[40]. - The Group's investment portfolio mainly comprised securities issued by listed companies, with a fair value loss on financial assets at FVTOCI of approximately HK28,466,000 in 2023[79]. - The Group holds a 3.32% equity interest in World Biotech, with an investment cost of HK60,740,000 as of June 30, 2024, accounting for about 14.2% of the Group's total assets[84]. Legal Proceedings - The Group was involved in legal proceedings related to claims against its subsidiary, Ever Robust, with a loan amount of HK67,574,473 being contested[101]. - The Group has not made any provisions for the legal proceedings as it is unable to reliably assess the amount of potential liabilities[109]. - The Group's legal proceedings include claims related to share placements and potential damages for dilution of shareholding[106]. Corporate Governance - The Audit Committee consists of three independent non-executive Directors, ensuring compliance with GEM Listing Rules and corporate governance standards[135]. - The Company is committed to good corporate governance practices, enhancing transparency and quality of disclosure[135]. - The Company has complied with the Corporate Governance Code provisions during the review period[134].
恒泰裕集团(08081) - 2024 - 中期业绩